Riverview Trust Co bought a new stake in The Cooper Companies, Inc. (NYSE:COO – Get Rating) in Q1, according to the company in its latest filing with the Securities and Exchange Commission. The company bought 70 shares of the medical device company, valued at around $29,000.
Other institutional investors have also recently bought and sold shares of the company. PrairieView Partners LLC acquired a new stake in Cooper Companies in Q4 valued at approximately $33,000. Trust Co. of Vermont acquired a new stake in Cooper Companies in Q4 valued at approximately $36,000. Harel Insurance Investments & Financial Services Ltd. increased its stake in Cooper Companies shares by 56.5% in the fourth quarter. Harel Insurance Investments & Financial Services Ltd. now owns 97 shares of the medical device company worth $41,000 after acquiring 35 more shares in the last quarter. Missouri Trust & Investment Co acquired a new position in Cooper Companies stock in the fourth quarter worth $42,000. Finally, Ellevest Inc. increased its stake in Cooper Companies shares by 31.3% in the fourth quarter. Ellevest Inc. now owns 109 shares of the medical device company worth $46,000 after acquiring 26 more shares in the last quarter. Hedge funds and other institutional investors hold 98.38% of the company’s shares.
Separately, director Gary S. Petersmeyer sold 300 shares of the company in a trade on Monday, April 11. The shares were sold at an average price of $410.55, for a total value of $123,165.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, accessible via the SEC’s website. 1.70% of the shares are held by insiders.
Several equity analysts have commented on COO shares. StockNews.com began covering Cooper Company stocks in a research note on Thursday, March 31. They issued a “holding” rating for the company. Stephens lowered his price target on Cooper Companies shares from $500.00 to $460.00 and set an “overweight” rating for the company in a Friday, June 3 research note. Citigroup raised its price target on Cooper Companies stock from $405.00 to $406.00 and gave the stock a “buy” rating in a Monday, June 6 research note. Wells Fargo & Company lowered its price target on Cooper Companies stock from $495.00 to $380.00 and set an “overweight” rating for the company in a Monday, May 23 research note. Finally, Piper Sandler lowered her price target on Cooper Companies shares from $500.00 to $430.00 and set an “overweight” rating for the company in a Tuesday, May 31 research note. Three equity research analysts gave the stock a hold rating and eight gave the company a buy rating. According to MarketBeat, the stock currently has a consensus rating of “moderate buy” and an average price target of $432.89.
Shares of COO opened at $318.51 on Monday. The company has a current ratio of 1.05, a quick ratio of 0.69 and a debt ratio of 0.33. The company has a fifty-day moving average price of $335.38 and a 200-day moving average price of $380.39. The company has a market capitalization of $15.71 billion, a P/E ratio of 16.73, a PEG ratio of 2.19 and a beta of 0.92. The Cooper Companies, Inc. has a 12-month low of $297.34 and a 12-month high of $463.59.
Cooper Companies (NYSE:COO – Get Rating) last reported quarterly results on Thursday, June 2. The medical device company reported earnings per share of $3.24 for the quarter, missing analyst consensus estimates of $3.43 per ($0.19). Cooper Companies had a net margin of 30.20% and a return on equity of 9.48%. The company posted revenue of $829.80 million in the quarter, compared to $821.03 million expected by analysts. During the same period last year, the company earned earnings per share of $3.38. Cooper Companies revenue increased 15.3% year over year. On average, stock analysts expect The Cooper Companies, Inc. to post EPS of 13.19 for the current year.
Company Profile Cooper Companies (Get a rating)
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures and markets contact lens wearers. The Company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lenses, including lenses that correct presbyopia and farsightedness; and toric and multifocal lenses including lenses correcting vision problems, such as astigmatism, presbyopia, myopia, dry eye and eye strain in the Americas, Europe, Middle East, Africa and Asia-Pacific.
Want to see which other hedge funds hold COO? Visit HoldingsChannel.com for the latest 13F filings and insider trading for The Cooper Companies, Inc. (NYSE:COO – Get Rating).
Receive daily news and reviews for Cooper Companies – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Cooper companies and related companies with MarketBeat.com’s free daily email newsletter.